RxSight, Inc. Common Stock (NASDAQ: RXST) last traded at $6.25, up 2.63% on the session. The quote above updates while this page is open; the figures below are drawn from RxSight, Inc. Common Stock’s own filings and are restated only when a new one is published.
RxSight, Inc. Common Stock trades on NASDAQ under the ticker RXST. Its market capitalisation is $259.96 million.
Valuation measures for RxSight, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $259.96M |
|---|---|
| Enterprise value | $335.97M |
| Price / sales | 2.04 |
| Price / book | 0.99 |
| Beta | 1.20 |
Trailing-twelve-month figures tagged in RxSight, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $127.58M |
|---|---|
| Net income (TTM) | -$46.95M |
| EPS (TTM) | -$1.13 |
| Gross margin | 76.95% |
| Operating margin | -43.20% |
| Return on equity | -17.83% |
| Cash | $13.35M |
Range and volume for RXST over the past 52 weeks.
| 52-week high | $13.22 |
|---|---|
| 52-week low | $4.48 |
| Volume | 1.54M |
| Average volume | 1.15M |
| Previous close | $6.09 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.